Hans‐peter Dienes

Hans‐peter Dienes's AcademicInfluence.com Rankings

Hans‐peter Dienes

Philosophy

#8795

World Rank

#12243

Historical Rank

Logic

#5813

World Rank

#7253

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Hans‐peter Dienes's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Hans‐peter Dienes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hans‐peter Dienes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Simplified criteria for the diagnosis of autoimmune hepatitis (2008) (1456)
MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma (2007) (449)
Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer (2007) (446)
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. (2003) (421)
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas (2001) (360)
Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer: Implications for Response Classification (2005) (351)
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. (1997) (351)
Granulocyte‐macrophage‐colony‐stimulating factor enhances immune responses to melanoma‐associated peptides in vivo (1996) (325)
Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals (1999) (277)
Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells (1992) (213)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. (2010) (195)
Non-A, non-B hepatitis in chimpanzees and marmosets. (1981) (194)
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection (2013) (193)
Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain (1994) (190)
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. (2003) (185)
MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis (2004) (176)
Histologic Observations in Human Hepatitis Non‐A, Non‐B (2007) (173)
Proapoptotic and antiproliferative potential of selective cyclooxygenase‐2 inhibitors in human liver tumor cells (2002) (167)
Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice (1997) (166)
TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. (1999) (166)
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. (2013) (166)
Peginterferon plus adefovir versus either drug alone for hepatitis delta. (2011) (163)
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. (1996) (161)
Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer (2008) (158)
Lymph Node Size and Metastatic Infiltration in Colon Cancer (1999) (150)
Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. (2008) (148)
Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction (2011) (142)
Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. (1998) (134)
Serologic Markers Compared With Liver Biopsy for Monitoring Disease Activity in Autoimmune Hepatitis (2008) (133)
Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. (1999) (125)
Role of sinusoidal endothelial cells of the liver in concanavalin A‐induced hepatic injury in mice (1996) (124)
Long‐term follow‐up of antimitochondrial antibody–positive autoimmune hepatitis (2008) (124)
Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease (2011) (123)
TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. (1999) (122)
High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer (2004) (119)
Beta‐catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E‐cadherin and accumulation of p53, but not with expression of conventional WNT‐1 target genes (2003) (118)
Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. (2011) (113)
Splenectomy in proximal gastric cancer: Frequency of lymph node metastasis to the splenic hilus (2001) (112)
Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non‐A, Non‐B (1987) (112)
Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas (1998) (111)
Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. (2008) (109)
Expression of MMP‐2 is associated with progression and lymph node metastasis of gastric carcinoma (2001) (107)
Hepatic granulomas: histological and molecular pathological approach to differential diagnosis–a study of 442 cases (2008) (106)
Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection (2006) (106)
Uptake of microparticle‐adsorbed protein antigen by bone marrow‐derived dendritic cells results in up‐regulation of interleukin‐1α and interleukin‐12 p40/p35 and triggers prolonged, efficient antigen presentation (1995) (105)
MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. (2012) (102)
Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR (2008) (101)
Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction (1997) (100)
Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. (1997) (99)
Prognostic impact of p21/waf1/cip1 in colorectal cancer (2000) (98)
Quantitative HBsAg and HDV‐RNA levels in chronic delta hepatitis (2010) (97)
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl‐Lewisa and sialyl‐Lewisx antigens in colorectal adenocarcinoma (2002) (97)
Prospective Randomized Comparison of Minilaparoscopy and Percutaneous Liver Biopsy: Diagnosis of Cirrhosis and Complications (2007) (96)
The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. (2008) (95)
Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. (2005) (90)
Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. (1987) (89)
Predicting Recurrence and Survival in Patients with Laryngeal Cancer by Means of DNA Cytometry, Tumor Front Grading, and Proliferation Markers (1995) (87)
Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease (2019) (87)
Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. (1993) (86)
Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. (1998) (84)
Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. (1985) (83)
Clonal Exhaustion as a Mechanism to Protect Against Severe Immunopathology and Death from an Overwhelming CD8 T Cell Response (2013) (83)
Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues (2003) (83)
Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations. (2015) (81)
Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. (1997) (81)
The role of Epstein-Barr virus in acute and chronic hepatitis. (2006) (79)
Characteristics and Long-term Prognosis of the Autoimmune Hepatitis/Primary Sclerosing Cholangitis Overlap Syndrome (2009) (79)
Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice. (2004) (79)
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. (1997) (79)
Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29 (2012) (78)
Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus (2002) (77)
Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. (2006) (76)
Hepatocyte growth factor-stimulated invasiveness of monocytes. (2000) (76)
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. (1990) (75)
Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation (2017) (73)
Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation. (1994) (72)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial. (2019) (71)
Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to Pre‐S‐ and S‐encoded viral surface antigens (1991) (71)
Intercellular communication via gap junctions in activated rat hepatic stellate cells. (2005) (70)
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. (2009) (70)
Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis (2001) (70)
In vivo confocal laser endomicroscopy of the human liver: a novel method for assessing liver microarchitecture in real time. (2008) (70)
Parenchymal and nonparenchymal liver cells and their interaction in the local immune response. (1995) (69)
Receptor-mediated entry of hepatitis B virus particles into liver cells (1997) (69)
Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity (1991) (68)
Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (1988) (67)
High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal Cancer (2005) (67)
The indications for liver biopsy. (2012) (67)
P16INK4A immunostaining is a strong indicator for high‐risk‐HPV‐associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low‐risk‐HPV‐infection in head and neck papillomas and laryngeal dysplasias (2014) (66)
Autoimmune hepatitis and overlap syndromes. (2002) (66)
Experimental autoimmune hepatitis: Disease induction, time course and t‐cell reactivity (1990) (66)
Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. (1995) (66)
Histopathological Subtypes and Prognosis of Gastric Cancer Are Correlated with the Expression of Mucin-Associated Sialylated Antigens: Sialosyl-Lewisa, Sialosyl-Lewisx and Sialosyl-Tn (1998) (65)
Increased Galectin-3 Expression in Gastric Cancer: Correlations with Histopathological Subtypes, Galactosylated Antigens and Tumor Cell Proliferation (2000) (64)
Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. (1984) (64)
Thomsen‐Friedenreich antigen presents as a prognostic factor in colorectal carcinoma (2000) (64)
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks (2012) (61)
Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. (1994) (61)
Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. (2009) (60)
EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients (2017) (60)
TNF-induced target cell killing by CTL activated through cross-presentation. (2012) (60)
New Lineage of Lassa Virus, Togo, 2016 (2018) (59)
Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category. (2014) (59)
Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses (2013) (58)
Suppression of murine experimental autoimmune hepatitis by T‐cell vaccination or immunosuppression (1998) (58)
Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth (1990) (54)
Pathology of the liver sinusoids (2014) (54)
Histologic features in autoimmune hepatitis. (1989) (53)
A concerted action of HNF4α and HNF1α links hepatitis B virus replication to hepatocyte differentiation (2008) (53)
Randomized, double blind, placebo-controlled trial of low dose iodide in endemic goiter. (1997) (53)
Sinusoidal endothelial cells from guinea pig liver synthesize and secrete cellular fibronectin in vitro (1987) (52)
O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY (2014) (51)
Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors. (2011) (51)
Pathology of Immune-Mediated Liver Injury (2010) (50)
Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. (1990) (50)
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer (2004) (49)
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. (1991) (49)
Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. (2008) (49)
Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago–gastric junction and proximal stomach (2003) (47)
Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry. (2001) (46)
Detection of hepatitis C virus in paraffin‐embedded liver biopsies of patients negative for viral RNA in serum (1999) (46)
Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis. (2010) (46)
White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study. (2015) (45)
Hepatitis C virus infection triggers a tumor‐like glutamine metabolism (2017) (44)
Heterogeneity of Squamous Cell Carcinomas of the Head and Neck‐Analysis of Tumor Biologic Factors and Proliferation Rates (1996) (43)
A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. (2008) (43)
Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode. (1999) (43)
Decreased hepatocyte membrane potential differences and GABAa‐β3 expression in human hepatocellular carcinoma (2007) (42)
Current pathogenetic and molecular concepts in viral liver carcinogenesis (1993) (42)
Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. (1999) (42)
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta (2014) (42)
Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts. (2009) (42)
Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification (2007) (41)
Differences between Biopsy- or Specimen-related Laurén andWorld Health Organization Classification in Gastric Cancer (2002) (41)
Hepatocellular expression of lymphocyte function—associated antigen 3 in chronic hepatitis (1991) (41)
Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. (2005) (40)
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. (2004) (40)
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. (2010) (40)
Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. (2005) (39)
Binding properties of mechanically and enzymatically isolated hepatocytes for IgG and C3. (2008) (39)
Bioluminescence imaging allows measuring CD8 T cell function in the liver (2010) (38)
The role of autoimmunity in hepatitis C infection. (1995) (38)
Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. (1986) (38)
Changes in the extracellular matrix of the vein wall--the cause of primary varicosis? (2000) (38)
Hepatic steatosis in organ donors: disparity between surgery and histology? (2009) (37)
Endothelin-1 Induces NF-κB via Two Independent Pathways in Human Renal Tubular Epithelial Cells (2007) (37)
Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. (2008) (37)
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis (2011) (36)
Histological Grading in Gastric Cancer by Ming Classification: Correlation with Histopathological Subtypes, Metastasis, and Prognosis (2005) (36)
Smad4 deficiency in cervical carcinoma cells (2005) (36)
[Liver metastases: incidence and histogenesis]. (2005) (35)
Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis (2012) (35)
Simplified Diagnostic Criteria for Autoimmune Hepatitis (2006) (35)
Apoptosis and expression of bcl‐2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung (1998) (35)
[Myelolipoma of the adrenal gland]. (1984) (34)
Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti‐hepatitis b e—positive chronic hepatitis (1995) (34)
The role of Ito cells in the biosynthesis of HGF-SF in the liver. (1993) (34)
Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma (2002) (34)
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis (2017) (34)
Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. (2010) (34)
Development of Hepatocellular Carcinoma Associated with Anabolic Androgenic Steroid Abuse in a Young Bodybuilder: A Case Report (2012) (34)
[Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]. (2001) (33)
Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. (2013) (33)
Nuclear translocation of β‐catenin and decreased expression of epithelial cadherin in human papillomavirus‐positive tonsillar cancer: an early event in human papillomavirus‐related tumour progression? (2011) (33)
Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. (2005) (31)
Detection of mitochondrial antibodies directed against the primary biliary cirrhosis (M2) antigen by an enzyme-linked immunosorbent assay (ELISA). (1983) (31)
The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. (1990) (31)
Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. (2002) (31)
Liver biopsy in primary biliary cirrhosis: Clinicopathological data and stage (2009) (31)
Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. (2010) (30)
Expression of β-Catenin, MUC1 and c-Met in Diffuse-type Gastric Carcinomas: Correlations with Tumour Progression and Prognosis (2010) (30)
Liver biopsy in hepatitis C. (1999) (29)
Liver membrane autoantibodies in chronic active hepatitis. Studies on mechanically and enzymatically isolated rabbit hepatocytes. (1987) (29)
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. (2012) (29)
Kinetics of miR-122 Expression in the Liver during Acute HCV Infection (2013) (29)
Immunoreactivity of Monoclonal Antibody BW835 Represents a Marker of Progression and Prognosis in Early Gastric Cancer (2001) (28)
Ultrastructural localization of interferon‐producing cells in the livers of patients with chronic hepatitis B (1991) (27)
Acute hepatotoxicity of the polycyclic musk 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphtaline (AHTN). (1999) (27)
Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin (2013) (27)
Non‐invasive fibrosis score for hepatitis delta (2017) (27)
Skip metastasis in nonsmall cell lung carcinoma (2004) (27)
Signet ring stomach cancer: morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1). (1987) (26)
Anti-Hdv Immunoglobulin M Testing in Hepatitis Delta Revisited: Correlations with Disease Activity and Response to Pegylated Interferon-α2A Treatment (2012) (26)
Ex vivo analysis of antineoplastic agents in precision‐cut tissue slices of human origin: effects of cyclooxygenase‐2 inhibition in hepatocellular carcinoma (2006) (26)
Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis. (2000) (25)
Protein kinase C α regulates nuclear pri-microRNA 15a release as part of endothelin signaling. (2011) (25)
TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer. (2010) (25)
Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. (2002) (25)
Lymphocytes from hepatic inflammatory infiltrate kill rat hepatocytes in primary culture (1990) (24)
Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report. (2005) (24)
Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma (2013) (23)
A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer (2020) (23)
[Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. (2010) (23)
Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol. (2004) (23)
Therapy of prednisone-refractory collagenous colitis with budesonide (1999) (23)
Application of immunoelectron microscopy for identification of T lymphocyte subsets and HLA DR antigen positive cells in tissue. (1984) (22)
Hepatocellular carcinoma after thorotrast exposure: Establishment of a new cell line (Mz‐Hep‐1) (1985) (22)
Herpes simplex virus type 1 and 2 in the adrenal glands: Replication and histopathology (2005) (22)
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. (2012) (22)
Lewis(y) antigen (CD174) and apoptosis in gastric and colorectal carcinomas: correlations with clinical and prognostic parameters. (2006) (22)
Expression of Ia-antigens on guinea pig Kupffer cells. Studies with monoclonal antibodies. (1986) (21)
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group (2022) (21)
[Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet)]. (2004) (21)
[4] 72 WEEK DATA OF THE HIDIT-1 TRIAL: A MULTICENTER RANDOMISED STUDY COMPARING PEGINTERFERON α-2a PLUS ADEFOVIR VS. PEGINTERFERON α-2a PLUS PLACEBO VS. ADEFOVIR IN CHRONIC DELTA HEPATITIS (2007) (20)
Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens. (2003) (20)
Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1. (1999) (20)
Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis. (2001) (19)
Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases. (2006) (19)
Expression of the 60 kDa heat shock protein in normal and inflamed liver. (1993) (18)
The role of insulin‐like growth factor II in the malignant transformation of rat liver oval cells (1997) (18)
Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. (1987) (18)
Analysis of microsatellite instability in colorectal carcinoma by microfluidic-based chip electrophoresis (2008) (18)
Uptake of bead-adsorbed versus soluble antigen by bone marrow derived dendritic cells triggers their activation and increases their antigen presentation capacity. (1995) (18)
p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. (2001) (18)
Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells. (2013) (17)
Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas. (2001) (17)
Soft tissue osteoma: tumour entity or reactive lesion? Paraarticular soft tissue osteoma of the hip (2004) (17)
Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity. (1989) (16)
Congenital Absence of the Portal Vein with Splenomegaly and Hypersplenism in a Young Woman (2003) (16)
Treatment of patients with malignant melanoma by monoclonal ganglioside antibodies (1988) (16)
Clinical significance of nm23 gene expression in gastric cancer. (2007) (16)
Segmental Atrophy of the Liver: A Distinctive Pseudotumor of the Liver With Variable Histologic Appearances (2011) (16)
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. (2021) (16)
Alterations of the extracellular matrix of venous walls in varicous veins. (1999) (15)
A monoclonal antibody directed against an organ-specific liver cell membrane antigen in rabbits. (1984) (15)
Chronic Hepatitis E is associated with cholangitis (2019) (14)
P16(INK 4a) and Ki-67 expression in human papilloma virus-related head and neck mucosal lesions. (2015) (14)
Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in rat liver parenchymal and non-parenchymal cells. (1988) (14)
Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis? (1997) (14)
Comparative Quantitative Analysis of Macrophage Populations Defined by CD68 and Carbohydrate Antigens in Normal and Pathologically Altered Human Liver Tissue (1998) (14)
Precision cut tissue slices of the liver as morphological tool for investigation of apoptosis. (2005) (14)
Rapid immunohistochemical detection of tumor cells in gastric carcinoma. (2006) (14)
Dominance of CD4+ alpha/beta T-cells and inferior role of innate immune reaction in liver metastases. (2003) (14)
[Biopsy diagnosis of chronic hepatitis]. (2004) (14)
De novo expression of nonhepatocellular cytokeratins in Mallory body formation (1998) (14)
Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation (2005) (14)
A common epithelial cell surface antigen (EPM-1) on gastrointestinal tumors and in human sera. (1987) (13)
Unusual intranuclear inclusions in malignant fibrous histiocytoma: presence in primary tumor, metastases, and xenografts. (1982) (13)
Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis (2009) (13)
Autoimmune hepatitis (1996) (13)
Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis. (1996) (13)
Electron microscopic observations on primary hepatocyte cultures infected with herpes simplex virus Types I and II (1984) (13)
Significant Down-Regulation of the Plasminogen Activator Inhibitor 1 mRNA in Pancreatic Cancer (2008) (13)
Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro. (1987) (13)
HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer. (2006) (12)
A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation. (2003) (12)
Cryopreservation of precision cut tissue slices (PCTS): investigation of morphology and reactivity. (2011) (12)
Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. (1994) (12)
Hepatic steatosis in organ donors – disparity between surgery and histology? (2009) (12)
The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha. (1996) (12)
Detection of Opportunistic Infections by Low-density Microarrays: A Diagnostic Approach for Granulomatous Lymphadenitis (2007) (12)
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy (2018) (12)
First case of isolated small bowel transplantation at the university of cologne: rejection-free course under quadruple immunosuppression and endoluminal monitoring with video-capsule. (2004) (12)
Is the Urokinase-type Plasminogen Activator System a Reliable Prognostic Factor in Gastric Cancer? (2006) (12)
Ha-rasVal12 but not p53Ser247 leads to a significant neoplastic transformation rate of the putative rat liver stem cells (oval cell). (1996) (11)
Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: Correlation with disease activity and response to interferon‐α (1994) (11)
Establishment and characterization of a nontumorigenic cell line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. (1997) (11)
p16, cyclin D1 and Rb expression in colorectal carcinomas: Correlations with clinico-pathological parameters and prognosis. (2008) (11)
Analysis of liver‐specific protein LSP using murine monoclonal antibodies (1987) (11)
Ultrastructural lesion in autoimmune hepatitis and steps of the immune response in liver tissue. (1991) (11)
Quantification of MET and hepatocyte growth factor/scatter factor expression in colorectal adenomas, carcinomas and non-neoplastic epithelia by quantitative laser scanning microscopy. (2007) (11)
Long-term follow-up of patients with chronic hepatitis B after interferon treatment. (1996) (11)
Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications. (1999) (10)
COX-2 expression and effects of COX-2 inhibition in colorectal carcinomas and their liver metastases. (2010) (10)
Microtubules and intermediate filaments of herpes simplex virus infected cells (2005) (10)
Therapeutic aspects of autoimmune liver disease in children (2005) (10)
Lymph node revealing solution in gastric carcinoma does not provide upstaging of the N-status. (2005) (10)
Improving the efficacy of targeted trials by multiple-marker analysis in castration-resistant prostate cancer. (2011) (10)
Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin's lymphoma infiltration. (2010) (10)
Florid ischemic cholangitis due to leucocytoclastic vasculitis (2004) (10)
[Primary cholangiocarcinoma in a case of Caroli's disease: case report and literature review]. (2006) (9)
Colonic Ornithine Decarboxylase in Inflammatory Bowel Disease: Ileorectal Activity Gradient, Guanosine Triphosphate Stimulation, and Association with Epithelial Regeneration but Not the Degree of Inflammation and Clinical Features (2006) (9)
Nodular nonsuppurative panniculitis in association with primary biliary cirrhosis and Hashimoto's thyroiditis. (1996) (9)
Correlation of virus replication, cytokine (TNF-α and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence (2005) (8)
Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2 (1991) (8)
Pathogenesis and clinical relevance of post-infantile giant cell hepatitis (PIGCH) (1993) (8)
Induction of apoptosis and up-regulation of cellular proliferation in oral leukoplakia cell lines inside electric field. (2012) (8)
[HPV-associated tonsillar cancer. An update]. (2004) (8)
Intracellular accumulation of incompletely processed transforming growth factor-alpha polypeptides in ground glass hepatocytes of chronic hepatitis B virus infection. (1996) (8)
Targeting Myofibroblasts in Model Systems of Fibrosis by an Artificial α-Smooth Muscle-Actin Promoter Hybrid (2009) (8)
Infection of murine hepatocyte cultures by herpes simplex virus (HSV) 1 and 2. (2008) (8)
[Current aspects of liver allograft pathology]. (2011) (8)
[Epithelial-mesenchymal transition of biliary epithelial cells in advanced liver fibrosis]. (2007) (8)
Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas. (2001) (7)
Studies for estimating the biologic behavior and prognosis of paragangliomas in the head and neck. (1995) (7)
[Acute interstitial nephritis following piperacillin]. (1989) (7)
Modulation of MUC1 and blood group antigen expression in gastric adenocarcinoma cells by cytokines. (2003) (7)
Ossifying renal tumor of infancy (ORTI) - a rare diagnosis. (2011) (7)
Long-term follow-up of patients with chronic hepatitis C after interferon-alpha treatment. (1996) (7)
Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4−/− Mouse Model (2013) (7)
The impact of cytology on the bronchoscopic diagnosis of lung cancer (2004) (7)
Postoperative fulminant varicella zoster virus hepatitis with fatal outcome: a case report. (2008) (7)
[Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection]. (1995) (7)
Haemophagocytic lymphohistiocytosis associated with fulminant hepatitis and multiorgan failure following primary Epstein–Barr virus and herpes simplex virus type 1 infection (2017) (6)
Development of rat DC by in vitro culture of bone marrow cells. (1995) (6)
Hepatitis A-like non-A, non-B hepatitis: Light and electron microscopic observations of three cases (2004) (6)
Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes. (2005) (6)
Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta (2014) (6)
Role of the Ha‐ras gene in the malignant transformation of rat liver oval cells (1997) (6)
Immunoglobulin heavy chain gene analysis in bone marrow biopsies and corresponding lymph node specimens: dependency on pre-treatment, histological subtype and extension of B-cell lymphoma. (2008) (6)
Well-differentiated hepatocellular neoplasm of uncertain malignant potential--reply. (2015) (6)
Loss of surface fibronectin after infection of cultured cells by HSV-1 and 2 (2005) (6)
[Malignant lymphomas of the liver: new diagnostic algorithms]. (2006) (6)
HCV-associated cryoglobulinaemia presenting with vasculitis, hepatitis, and glomerulonephritis - a therapeutic dilemma. (1996) (5)
[Pleomorphic adenoma (mixed tumor) of the external auditory canal. Differential diagnosis of the tumors of the ceruminal glands]. (1999) (5)
Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion (2022) (5)
An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells. (1993) (5)
[Liver biopsy in chronic hepatitis C. Histopathology, molecular diagnostic analysis, and implications for therapeutic management]. (2001) (5)
Micro RNAs mir‐106a, mir‐122 and mir‐197 are increased in severe acute viral hepatitis with coagulopathy (2016) (5)
280 MICRORNA-29: A NOVEL ANTIFIBROGENIC MEDIATOR IN LIVER FIBROGENESIS (2009) (5)
[Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?]. (2005) (5)
Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment. (1995) (4)
Membrane Expression of Autoantigens on Mechanically and Enzymatically Isolated Hepatocytes (1986) (4)
[Highly differentiated squamous epithelial carcinoma as a late complication of post-traumatic osteomyelitis]. (1999) (4)
[Chronic active hepatitis: recurrence after long-term immunosuppressive therapy in spite of normal liver histology]. (1983) (4)
[The central odontogenic fibroma. A rare tumor]. (2003) (4)
Veno-occlusive disease of the liver in Hodgkin's disease prior to and resolution following chemotherapy. (1995) (4)
Crystalloid lysozyme inclusions in Paneth cells of vitamin A-deficient rats (1990) (4)
[Fatal bleeding complications caused by Evans syndrome (autoimmune thrombocytopenia and hemolytic anemia) and type II autoimmune hepatitis in a 56-year-old patient]. (2002) (4)
[Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease]. (2010) (4)
[Histopathology in liver transplantation]. (2008) (4)
[Autopsy records in Cologne from 1914 to 1960: changes in diseases, society and institution]. (2008) (4)
Characterization of circulating immune complexes in chronic non-A, non-B hepatitis. (1983) (3)
Clinical Significance of nm 23 Gene Expression in Gastric Cancer (2008) (3)
[Consequences of autopsies for the living : Causes of death in the clinical diagnosis "septic and toxic shock"]. (2017) (3)
Methodology and significance of the detection of liver‐kidney‐microsomal (lkm) autoantibodies in autoimmune‐type chronic active hepatitis (1987) (3)
HSV hepatitis in the mouse: A light and electron microscopic study with immunohistology and in situ hybridization (1988) (3)
Keratin 8 variants are associated with cryptogenic hepatitis (2012) (3)
Transplantationspathologie der Leber (2008) (3)
[Cytomegalovirus. Pathological-anatomical manifestations and detection methods]. (2011) (3)
1255 miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2013) (3)
Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha. (1997) (3)
Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection (1994) (3)
Chronic hepatitis : new concepts of pathogenesis, diagnosis and treatment : proceedings of the Falk Workshop held in Cologne, Germany, 27-28 January 2000 (2000) (3)
Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting. (1987) (3)
Direct ex vivo analysis of antineoplastic agents in precision cut human tissue culture-effects of Cyclooxygenase-2 inhibition in hepatocellular carcinoma (2004) (3)
Transmission of hepatitis-B-virus by pleural effusion containing Dane particles. (1981) (3)
[Adenocarcinoma of the stomach with heterotopic ossification. Case report and discussion of the pathogenesis]. (2002) (3)
691 IMPACT AND REGULATION OF AUTOREACTIVE CD8+ T CELLS IN A TRANSGENIC MOUSE MODEL OF AUTOIMMUNE HEPATITIS (2009) (3)
Spontaneous and antibody-dependent cellular immune reactions to ethanol-altered hepatoma cells. (2008) (3)
Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features. (1995) (3)
In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys (1993) (3)
Ha-ras(Va12) but not p53(Ser247) leads to a significant neoplastic transformation rate of the putative rat liver stem cells (oval cell) (1997) (3)
Quantitation of inflammatory und proliferative genes as disease markers in laser‐microdissected, formalin‐fixed and paraffinized glomeruli from human renal biopsies (2002) (3)
[The central odontogenic fibroma : A rare tumor]. (2003) (2)
[Lymph node dissection, stage migration and perioperative risk in rectal carcinoma]. (1996) (2)
microRNA-29 Regulates the Expression of Profibrogenic Mediators in Hepatic Stellate Cells (2010) (2)
A critical function of USF in HGF gene regulation mediated by a multiconsensus region. (2002) (2)
Treatment of Patients with Neuroectodermal Tumors by Monoclonal Ganglioside Antibodies (1987) (2)
Autoimmune hepatitis—is histology conclusive? (2021) (2)
Medullary thyroid cancer established in tissue culture (1987) (2)
Serum versus intrahepatic HCV RNA and liver histology (2002) (2)
Expression of a novel T-cell activation antigen on bile canaliculi. (1986) (2)
[The risk of endocrine activation in interventional procedures on paraganglioma of the head and neck]. (1988) (2)
[Adenocarcinoid of the appendix vermiformis]. (2005) (2)
Diagnose und Differenzialdiagnose des hepatozellulären Karzinoms (2006) (2)
[Growth factors in liver regeneration and hepatocarcinogenesis]. (1995) (2)
Pegylated interferon-alfa–2a plus adefovir combination therapy is superior to pegylated interferon-alfa–2a alone or adefovir monotherapy in reducing HBsAg levels in HDV-coinfected patients with low HBV viremia (2007) (2)
[Morphology of drug induced liver damage]. (2006) (2)
Biliary cytokeratin expression but not CD56 (N-CAM) expression aids in the differential diagnosis of non-neoplastic bile duct diseases. (2010) (2)
[Diagnosis and differential diagnosis of hepatocellular carcinoma]. (2006) (2)
Label-free analysis of microsatellite instability in colorectal carcinoma by on-chip electrophoresis (2005) (1)
Hepatocyte growth factor (HGF) acts as an antifibrotic mediator by prominent miRNA-29 induction (2011) (1)
Comparison of the lymphocytic infiltrate in Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) induced hepatitis (2004) (1)
TGF- b 1 in liver ﬁbrosis: an inducible transgenic mouse model to study liver ﬁbrogenesis (1999) (1)
[Merkel cell carcinoma: an endocrine differentiated tumor in the head-neck area]. (1991) (1)
P0576 : Impact of organ and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis D virus infection (2015) (1)
Simultaneous infection with non-A, non-B and B viruses in a patient exhibiting different histologic patterns of acute hepatitis. (2008) (1)
[Diagnostic relevance of lymph node size after 2-field lymph node excision in esophagus carcinomas]. (1998) (1)
Herpes simplex virus hepatitis and related problems. (1994) (1)
Fine-needle biopsy of parathyroid adenomas (1986) (1)
Cystic Medial Necrosis of the Internal Thoracic Artery: Case Report (1996) (1)
[Autoimmune hepatitis and autoimmune cholangitis]. (2005) (1)
[Acute fatty liver of pregnancy. A case report of the differential diagnosis of pregnancy-associated liver diseases]. (1986) (1)
Adenocarcinoid of the appendix vermiformis — A case report (2004) (1)
[Primary infection with Epstein-Barr virus in a 77-year-old patient with B symptoms and hepatitis -- a case report]. (2006) (1)
Identification of microRNA differentially expressed in hepatocellular carcinoma versus non-tumoral liver tissue (2007) (1)
Antigen-specific suppression of the experimental immune complex glomerulonephritis in rabbits by means of highly hot labelled antigen. (1984) (1)
In situ characterization of killer effector lymphocytes (S6F1-positive) in chronic viral hepatitis (1989) (1)
[Autoimmune hepatitis--new aspects of histopathology, ultrastructure and immunohistology]. (1988) (1)
Promoter regulation of the miR-29a/b1 gene by transforming growth factor-β in hepatic stellate cells and in hepatoma cells (2015) (1)
[Simultaneous inoculation of hepatitis B virus and non-A non-B agents on a chimpanzee: histopathology in relation to electron microscopic and immunologic findings]. (1981) (1)
[Glucagon-secreting malignant neuroendocrine tumor of the pancreas]. (2000) (1)
[Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis]. (2001) (1)
Oval cell lines as progenitor cells of cholangiocellular carcinoma (1993) (0)
1118 COMPLEX REGULATION OF THE microRNA-29a/b GENE BY TGF-beta SIGNALING (2013) (0)
Cytochrome-C release in hepatocellular carcinoma cell apoptosis induced by cyclooxygenase-2 inhibition: evidence for involvement of mitochondria dependent signalling (2004) (0)
531 MICRORNA-198, DOWNREGULATED IN HEPATO- CELLULAR CARCINOMA, INHIBITS CELL GROWTH OF HEPATOCELLULAR CARCINOMA CELLS (2009) (0)
Epithelial-mesenchymal transdifferentiation of bile duct cells during fibrogenesis due to cholestasis (2006) (0)
miR-125b regulates the Lin-28/IGF-II axis during hepatocellular carcinogenesis (2013) (0)
Expression of suppressor of cytokine signaling-3 protein in chronic hepatitis C virus infected liver tissue (2004) (0)
Autochthonous acute hepatitis E mimicking CMV infection. (2018) (0)
27 IMPACT OF DIFFERENTIALLY EXPRESSED MICRORNAS ON MYOFIBROBLASTIC TRANSDIFFERENTIATION OF HEPATIC STELLATE CELLS (2009) (0)
[Polyps of the sigmoid and rectum following ureterosigmoidostomy]. (1980) (0)
623 MICRORNA EXPRESSION IN BIOPSIES OF PATIENTS WITH CHRONIC HEPATITIS C AND THERAPY WITH PEGINTERFERON (2009) (0)
P.213 Apoptosis in acute and chronic experimental HCV infection (2006) (0)
497 BETA-ADRENERGIC BLOCKADE OF THE SYMPATHETIC NERVOUS SYSTEM DECELERATES PERIPORTAL FIBROSIS IN MDR2 KNOCKOUT MICE (2008) (0)
The pluripotency factor LIN28 is targeted by neuronal microRNAs participating in myofibroblastic differentiation (2011) (0)
miR-198 controls migration in hepatocellular carcinoma by regulation of Claudin 1 (2013) (0)
The role of microRNA-29 in collagen deposition during liver fibrogenesis (2009) (0)
Activation of Liver-Specific CD8+ and CD4+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis (2008) (0)
Liver Pathology of Wilson Disease (2019) (0)
Epstein-Barr virus (EBV)-carrying gastric carcinomas in Germany: a retrospective clinico-pathological study (2004) (0)
In situ activation of T-lymphocytes in chronic viral and autoimmune hepatitis (1989) (0)
[Definition and diagnosis of acute and chronic hepatitis C]. (2004) (0)
[Immunohistologic findings in paragangliomas in the area of the head and neck]. (1988) (0)
[Immunohistological demonstration of alpha-1-fetoprotein (AFP) in human testicular tumors]. (1978) (0)
Contribution of common variants in the complement factor H gene to fibrogenesis in chronic hepatitis C virus (HCV) infection (2007) (0)
miR-198 acts as novel tumorsuppressor miRNA in hepatocellular carcinoma (2010) (0)
GD3 ganglioside: A marker for the diagnosis and treatment of neuroectodermal tumors? (1986) (0)
New targets of miR-29 in cell communication during liver fibrogenesis (2011) (0)
[Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?]. (2009) (0)
Expression of EGFR and HER2/neu and absence of activating mutations in patients with castration-resistant prostate cancer. (2010) (0)
Pro12Ala mutation of peroxisome proliferator-activated receptor γ in patients with non-alcoholic fatty liver disease (2006) (0)
O87 P16 as a marker for human papillomavirus induced oropharingeal lesions (2007) (0)
Physiologic Behavioural Changes of Precancerous Leukoplakia Cell lines Exerted to Extremely Low Frequency Electric Field (2015) (0)
TGF-beta mediates transcriptional repression of miR–29 a/b1 during liver fibrosis (2012) (0)
1108 COMBINATION THERAPY WITH TELMISARTAN AND PROPRANOLOL PREVENTS DETERIORATION OF LIVER HISTOLOGY IN THE PSC-LIKE ABCB4 KNOCKOUT MOUSE MODEL (2010) (0)
Differentialdiagnose Gastrointestinaler Stromatumor/Granularzelltumor an der Papilla duodeni major (2007) (0)
The role of gamma/delta T-cells in chronic hepatitis (2004) (0)
Prevention of experimental immune complex glomerulonephritis by specific inactivation of immunoreactive cells. (1985) (0)
[Goodpasture syndrome: treatment initiation with plasmapheresis before histologic diagnostic verification]. (1996) (0)
Hemmung der Signalwirkung von Transforming Growth Factor ß durch RNA-Interferenz (2005) (0)
Cellular cytotoxicity against autologous hepatocytes in children with different forms of chronic hepatitis B (1990) (0)
Anti-HDV-IgM testing in hepatitis delta revisited: Correlations with disease activity and response to pegylated interferon alfa-2a treatment (2010) (0)
[Hepatitis C virus and autoimmune hepatitis: coincidence or causal relationship?]. (1996) (0)
[Unusual coincidence of partially active endocrine tumors]. (1998) (0)
Tissues Human Malignant Melanoma , Epithelial Tumors , and Normal inD 3 Immunohistochemical Localization of Ganglioside G Updated (2006) (0)
Apoptosis Investigation in Liver Metastases with Precision Cut Tissue Slices (PCTS) (2005) (0)
867 THE ROLE OF MICRORNA-125B REPRESSION IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMA (2010) (0)
1260 Hepatocyte membrane potentials and gabaergicactivity in human hepatocellular carcinoma. New insights into pathogenesis and potential diagnostic and/or therapeutic opportunities (2003) (0)
P58. HIF-1α mRNA is significantly overexpressed in esophageal squamous cell cancer but not associated with histopathologic regression following neoadjuvant chemoradiation (2006) (0)
Upregulation of AT1 Receptor in MDR2 Knockout Mice after low dose antifibrotic therapy with Telmisartan (2008) (0)
Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
Erratum (2007) (0)
Expression of suppressor of cytokine signaling-3 (SOCS-3) in hepatocellular carcinogenesis with respect to hepatitis B and C virus infection (2004) (0)
281 THE NEURONAL GUIDANCE CUE AND SURVIVAL FACTOR, NETRIN-1, IN LIVER FIBROGENESIS (2009) (0)
[Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer]. (2008) (0)
115 CD8 T CELL-MEDIATED IMMUNE RESPONSES AGAINST CROSS-PRESENTING LIVER SINUSOIDAL ENDOTHELIAL CELLS LEADS TO HEPATITIS (2009) (0)
Virus-like particles in a case of acute hepatitis with human GB virus-C viraemia (2001) (0)
Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells (2013) (0)
Alterations of miR-122-levels in biopsies and serum of chronic hepatitis C patients (2010) (0)
Liver histology in autoimmune hepatitis — diagnostic implications (2005) (0)
[Morphologic findings in experimental non-A, non-B hepatitis]. (1984) (0)
88 EXPRESSION OF THE THREE HEPATITIS B VIRUS SURFACE PROTEINS AND HBcAG IN THE LIVER OF CHILDREN WITH DIFFERENT FORMS OF CHRONIC HEPATITIS (1992) (0)
Adiponectin as a modulator of hepatic fibrosis in chronic HCV-Infection (2007) (0)
Stomach signet-ring cancer cell line (MZ-STO-1), established in tissue culture: Morphological characterization and antigenic profile (1986) (0)
Polypeptide growth factors participate in the process of malignant transformation of liver epithelial cells (1995) (0)
Evolution of PTLD following renal transplantation in a child (2009) (0)
P708 CHRONIC HEPATITIS E – THE SPECTRUM OF HISTOPATHOLOGY (2014) (0)
The loss of miR–198 is crucial for development and progression of hepatocellular carcinoma (2012) (0)
The pluripotency involved factors, Lin28 and Notch1 are targets of neuronal miRNAs in hepatic stellate cells (2015) (0)
Hepatotoxicity of phenprocumon (marcumar) (2004) (0)
The neuronal guidance cue and survival factor, Netrin-1, in liver fibrogenesis (2009) (0)
Differentiation of acute icteric autoimmune hepatitis from idiosyncratic drug-induced liver injury by histological and biochemical criteria (2018) (0)
435 ANTI-HDV-IgM AS A MARKER OF DISEASE ACTIVITY IN HEPATITIS DELTA (2013) (0)
Impact of treatment with Telmisartan plus Propranolol on liver tight junctions in MDR2-/- knockout mice (2017) (0)
Nup88 expression in hepatocellular carcinogenesis indicates interaction of hepatitis B virus with the nuclear pore (2004) (0)
microRNA-198, downregulated in hepatocellular carcinoma, represses cell growth of hepatoma cells (2009) (0)
[341] INHIBITION OF BETA-ADRENORECEPTORS RESULTS IN DELAYED FIBROSIS IN Abcb4 KNOCKOUT MICE (2007) (0)
Prospective randomised comparison of mini-Laparoscopy and percutaneous liver biopsy. Analysis of 1000 examinations (2005) (0)
Differentially expressed microRNAs during myofibroblastic transdifferentiation of Hepatic Stellate Cells (2009) (0)
Copy number variation of the CCL3L1 gene in chronic HCV infection: Influence on susceptibility and fibro-inflammatory response (2007) (0)
Fifty years of impact on liver pathology: a history of the Gnomes (2020) (0)
„Lymph node revealing solution“ beim Magenkarzinom — Bedeutung einer speziellen Aufarbeitungstechnik des Fettgewebes für das Lymphknotenstaging / Lymph Node Revealing Solution in Gastric Carcinoma: Impact of a New Processing Technique of Fat Tissue for Lymph Node Staging (2001) (0)
[74] MICRO-RNA GENE EXPRESSION PROFILE OF HCV-ASSOCIATED HEPATOCELLULAR CARCINOMA (2007) (0)
The tumor suppressor, miR-198, affects central pathways in tumorigenesis and in the immune response of hepatocellular carcinoma cells (2011) (0)
821 EXTRACELLULAR MIRNA-122 IS ELEVATED IN SERA OF PATIENTS WITH ACUTE LIVER FAILURE (2010) (0)
Induction of early murine cytomegalovirus infection by different reporter gene‐associated recombinant viruses (2006) (0)
[Deposition of keinoid fibers in gastrointestinal stromal tumors of the small intestine. Report of two cases and review of the literature]. (2002) (0)
684 Clinical characteristics and long-term prognosis of autoimmune hepatitis (AIH)/primary sclerosing cholangitis (PSC) overlap-syndrome (2003) (0)
[Immunohistological demonstration of serum proteins in formalin-fixed and native tissue--comparative studies in experimental glomerulonephritis in rats]. (1978) (0)
Definition and prognostic relevance of the salve grading and staging system for alcohol-related liver disease (2020) (0)
510 Inhibition of cyclooxygenase-2 suppresses the growth of human hepatocellular carcinoma implants in vivo (2003) (0)
Monoclonal antibodies define epithelial markers epm 1 exo 1 on gastrointestinal tumors in human secretions and serum samples (1987) (0)
Cdx2 and MUC2 expression in gastric carcinomas and their correlation with clinico-pathological parameters (2004) (0)
1042 NEW TARGETS OF MIR-29 IN CELL COMMUNICATION DURING LIVER FIBROGENESIS (2011) (0)
Relationship between laboratory data and liver histology in primary biliary cirrhosis (2008) (0)
Neuronal microRNA participate in myofibroblastic differentiation by targeting the pluripotency factor Lin-28 (2010) (0)
[Current problems of hepatitis]. (2008) (0)
Epithelial-mesenchymal transition of biliary epithelial cells during cholestatic fibrosis (2007) (0)
Cryopreservation of Precision Cut Tissue Slices (PCTS): Investigation of Morphology and Reagibility (2005) (0)
Incidence of genetic polymorphisms of the Peroxisome Proliferator-Activated Receptor γ and leptin receptor gene in patients with Non-Alcoholic Fatty Liver Disease (2007) (0)
MiR–198 is under- and miR–122 is overexpressed in HCV-associated hepatocellular carcinomas (2008) (0)
Fast and Reliable RNA in Situ Hybridisation Protocol for the Detection of Hepatitis C Virus in Formalin-Fixed Paraffin Embedded Tissue (2005) (0)
Decreased expression of microRNA-125b may contribute to the pathogenesis of hepatocellular carcinoma (2010) (0)
P57. Association of cyclooxygenase-2 expression with development and progression of Barrett’s metaplasia–dysplasia–carcinoma sequence and the environmental inflammatory reaction (2006) (0)
Blockade of the sympathicus by inhibition of beta-adrenoreceptors results in delayed fibrosis in MDR2 knockout mice (2007) (0)
[Delta infection in HBsAg carriers]. (1984) (0)
Stress Proteins in Inflammatory Liver Disease (2020) (0)
Distinct expression pattern of Nup88 (karyoporin) in chronic hepatitis B virus infection (2004) (0)
Epithelial (EPM-1) and exocrine (EXO-1) cell markers define gastrointestimal tumors (1986) (0)
[Diseases of the liver and bile ducts in AIDS]. (1989) (0)
Organ specificity of LSP. (1985) (0)
Phenprocoumon-induced liver injury (2015) (0)
BETA-ADRENERGIC BLOCKADE OF THE SYMPATHETIC NERVOUS SYSTEM DECELERATES PERIPORTAL FIBROSIS IN ABCB4 KNOCKOUT MICE (2008) (0)
703 IMMUNOHISTOCHEMICAL EXPRESSION ANALYSIS OF POTENTIAL MOLECULAR TARGETS FOR THE MANAGEMENT OF ANDROGEN-INDEPENDENT PROSTATE CANCER (2009) (0)
Significance of HBsAg and HDVRNA levels in patients with delta hepatitis recruited in the Hep-Net/International HDV intervention trial (2006) (0)
A novel non-MHC-I restricted CTL effector function mediated by TNF and XIAP (2011) (0)
[Inflammatory diseases of the vessels. Clinical aspects, immunopathology, characteristic features of therapy (author's transl)]. (1977) (0)
Biliary cytokeratin expression but not CD56 (N-CAM) expression aids in the differenzial diagnosis of non-neoplastic bile duct diseases (2010) (0)
Histopathology of chronic Hepatitis E (2015) (0)
[Comment on the consensus report, "Treatment of chronic B/D viral hepatitis and acute and chronic C virus hepatitis"]. (1998) (0)
Contents Vol. 57, 1999 (1999) (0)
COX-2 Expression and Effects of COX-2 Inhibition in Colorectal Carcinomas and their Liver Μetastases (2010) (0)
901 A LINK BETWEEN FREE FATTY ACIDS, FATTY ACID TRANSPORT PROTEINS AND APOPTOSIS IN THE PATHOGENESIS OF NASH (2008) (0)
Subject Index Vol. 57, 1996 (1996) (0)
Non-Invasive Clinical Scores to Identify Liver Fibrosis in Hepatitis Delta Patients (2016) (0)
Postersession IV: Gastroenterologie (1984) (0)
Highly malignant hepatic blastoma in an old adult (2004) (0)
Analysis of transforming growth factor-β1 gene polymorphisms in patients with Hepatitis C infection (2006) (0)
Histological NASH Score (NAS) Correlates with M30 Immune Expression in Obese Patients undergoing Bariatric Surgery (2008) (0)
Adiponectin as a putative modulator of hepatitis in chronic HCV-infection (2007) (0)
CD8 T cell mediated immune response against cross-presenting liver sinusoidal endothelial cells leads to hepatitis (2009) (0)
92 ENDOTHELIAL CELL CROSS-PRESENTATION INITIATES TNFA-DEPENDENT CD8 T CELL IMMUNITY AGAINST VIRUS-INFECTED HEPATOCYTES (2010) (0)
Functional Properties and Application of Ganglioside Antibodies to Patients with Malignant Melanoma (1989) (0)
799 KINETICS OF HEPATIC AND CIRCULATING MICRORNA-122 DURING EXPERIMENTAL ACUTE HCV INFECTION (2011) (0)
Spontaneous Chronic Liver Inflammation in a Transgenic Mouse Model of Autoimmune Hepatitis: Impact and Regulation of Autoreactive CD8+ T Cells (2009) (0)
[Clear cell tumor of the lung]. (2005) (0)
970 NEURONAL MICRORNAS, UPREGULATED DURING MYOFIBROBLASTIC DIFFERENTIATION, TARGET THE PLURIPOTENCY FACTOR LIN-28 (2010) (0)
956 MIR29 TARGETS THE POTENT PROFIBROGENIC GROWTH FACTORS SUCH AS IGF-I AS WELL AS TWO MEMBERS OF THE VEGF/PDGF FAMILY (2010) (0)
Cystic medical necrosis of the internal thoracic artery. (1996) (0)
[Coexpression of hepatocyte growth factor-scatter factor (HGF-SF) and HGF-SF receptors (c-met proto-oncogene) in mammalian brain]. (1994) (0)
The Role of Bile Acids and Nitric Oxide in Apoptosis of Liver Cells (2005) (0)
Endothelial cell cross-presentation initiates TNFα-dependent CD8 T cell immunity against virus-infected hepatocytes (2010) (0)
Parathyroid hormone (2007) (0)
So-called toxoplasmotic lymphadenitis "Piringer" -- immunohistological identification of Toxoplasma in formalin-fixed tissues. (1980) (0)
FUNCTIONAL, PHENOTYPIC AND MOLECULAR-BIOLOGICAL ANALYSIS OF TISSUE-INFILTRATING T-LYMPHOCYTES, WITH RESPECT TO PRIMARY BILIARY-CIRRHOSIS (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hans‐peter Dienes?

Hans‐peter Dienes is affiliated with the following schools: